Equites Radar

VEEV · Veeva Systems Inc.

Health Information ServicesUnited StatesAnalyst view: Buy

$186.24

+3.47% last session

End-of-day data · updated 2026-07-28

Mildly bearish1 bullish · 3 bearish technical signals
Consensus: Buy (1.90 from 28 analysts)
To mean target: +31.1%

Market cap

$32B

Enterprise value

$24B

Trailing P/E

34.5

Forward P/E

19.4

Dividend yield

Beta

0.94

Avg volume

3M

Employees

8K

2D change

5D change

8.29%

10D change

-0.47%

30D change

13.48%

60D change

11.54%

MTD change

5.56%

YTD change

-12.89%

Analyst Outlook

Consensus ratingBuy
Recommendation mean (1–5)1.90
Covering analysts28
Mean price target$244.14
Low price target$165.00
Upside to mean target+31.1%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)63.0
50-day MA$174.92
200-day MA$205.74
Price vs 50-day MA+15.0%
Price vs 200-day MA-2.2%
MACD histogram-0.44
Volume vs 3-month avg0.6×
52w low $151.4352w high $306.22

Analyst sentiment over time — VEEV

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-07-23

Latest call per bank · past 12 months

Citigroup

Neutral

$190

+2.0% vs price
▲ raised from $176Maintains · 2026-06-04

Goldman Sachs

Sell

$165

-11.4% vs price
▼ cut from $190Maintains · 2026-06-04

UBS

Neutral

$190

+2.0% vs price
▼ cut from $220Maintains · 2026-06-04

RBC Capital

Outperform

$275

+47.7% vs price
Reiterates · 2026-06-04

Wells Fargo

Overweight

$320

+71.8% vs price
▲ raised from $317Maintains · 2026-06-04

Barclays

Overweight

$235

+26.2% vs price
▼ cut from $250Maintains · 2026-06-04

Morgan Stanley

Equal-Weight

$215

+15.4% vs price
▲ raised from $205Maintains · 2026-03-05

JP Morgan

Overweight

$296

+58.9% vs price
▼ cut from $330Maintains · 2026-02-20

Recent rating actions

DateFirmActionRatingPrice target
2026-07-23GuggenheimInitiatesBuy$0.00 $232
2026-06-04CitigroupMaintainsNeutral$176 $190
2026-06-04MizuhoMaintainsOutperform$295 $270
2026-06-04Goldman SachsMaintainsSell$190 $165
2026-06-04OppenheimerReiteratesOutperform$225
2026-06-04Canaccord GenuityMaintainsHold$235 $220
2026-06-04StifelMaintainsBuy$245 $230
2026-06-04Evercore ISI GroupMaintainsIn-Line$240 $185

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-07-28

  • RSI (14): RSI is 63 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 15.0% above the 50-day MA ($174.92).
  • Price vs 200-day MA: Trading 2.2% below the 200-day MA ($205.74).
  • MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
  • MACD (12,26,9): MACD histogram is negative (-0.44) — short-term momentum is fading.
  • 52-week range: Price sits between the 52-week low ($151.43) and high ($306.22).

VEEV Price Chart

Loading chart for VEEV

Fundamentals

Revenue (TTM)$3.0B
EBITDA$1.0B
Free cash flow$1.0B
Operating cash flow$2.0B
Book value / share$44.83
Net debt / EBITDA-7.0
WACC11.0%
Revenue growth16.00%
Earnings growth15.00%

About Veeva Systems Inc.

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

More in Health Information Services

Screen VEEV against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.